At a glance
ClinicalIndex Comparison RecordN/ACompleted· 100 enrolled
Drug / intervention
Commercial Nucleus Cochlear Implant Systemsdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Cochlear Implant and Healthy Aging: A Multinational, Multicentre Observational Study
In Brief
An observational study evaluating Commercial Nucleus Cochlear Implant Systems for Hearing Loss. Completed, enrolled 100 participants across 8 sites in 4 countries.
Detailed Summary
The purpose of this study is to show that cochlear implant treatment improves the overall health related quality of life and general well-being in elderly individuals.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHearing Loss
CountriesFrance, Israel, Italy, Spain
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedMar 2017
Enrollment StartNov 2017
Primary CompletionMar 2022
TodayJul 2026
First PostedMar 7, 2017
Enrollment StartNov 6, 2017
Primary CompletionMar 21, 2022
TodayJul 2, 2026
Enrollment to primary: 4.4 yearsPosted 9.3 years ago
Interventions
Commercial Nucleus Cochlear Implant Systemsdevice
Commercially available Nucleus Cochlear Implant Systems, including Data Logging functionality